Table 4 The most different phenotype pairs within multi-phenotype disease genes by the mLOF score

From: Prevalence of loss-of-function, gain-of-function and dominant-negative mechanisms across genetic disease phenotypes

Gene

LOF-like phenotype

mLOF

non-LOF-like phenotype

mLOF

SMCHD1

Facioscapulohumeral muscular dystrophy 2

0.656

Bosma Arhinia Microphthalmia Syndrome

0.274

KRAS

Cardiofaciocutaneous syndrome 2

0.623

Multiple myeloma

0.296

TP63

Rapp-Hodgkin syndrome

0.653

Split-Hand/foot malformation 4

0.329

PRPF8

Retinitis pigmentosa

0.656

Retinitis pigmentosa 13

0.339

SMARCB1

Schwannomatosis

0.63

Coffin-Siris syndrome 3

0.318

GNAS

Pseudopseudohypoparathyroidism

0.659

Pituitary adenoma 3, multiple types, somatic

0.346

BRAF

Noonan syndrome 1

0.632

Multiple myeloma

0.321

ABCB11

Cholestasis, progressive familial intrahepatic 2

0.638

Cholestasis, intrahepatic, of pregnancy 3

0.33

CAV3

Long QT syndrome 9

0.598

Rippling muscle disease

0.294

MTOR

Renal cell carcinoma, papillary, 1, familial and somatic

 0.619

CEBALID syndrome

0.32 

ADCY5

Dyskinesia with orofacial involvement, autosomal recessive

0.645

Dyskinesia, familial, with facial myokymia

0.364

AARS1

Epileptic encephalopathy, early infantile, 29

0.644

Charcot-Marie-Tooth disease, axonal, type 2 N

0.366

LRP6

Tooth agenesis, selective, 7

0.656

Coronary artery disease, autosomal dominant 2

0.378

AIFM1

Deafness, X-linked 5

0.585

Spondyloepimetaphyseal dysplasia, X-linked, with mental deterioration

0.311

ARX

Mental retardation, X-linked, with or without seizures, ARX-related

0.637

Corpus callosum, agenesis of, with abnormal genitalia

0.368

LHCGR

Hypergonadotropic hypogonadism

0.567

Precocious puberty, male

0.301

TWNK

Perrault syndrome 5

0.61

Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3

0.346

ACTA1

Congenital myopathy 2B, severe infantile, autosomal recessive

0.656

Congenital myopathy 2 C, severe infantile, autosomal dominant

0.395

TP53

Breast cancer

0.648

Medulloblastoma

0.394

IMPG2

Macular dystrophy, vitelliform, 5

0.648

Macular dystrophy, vitelliform, 2

0.395

HBA2

Heinz body anemias

0.651

Methemoglobinemia, Alpha type

0.406

SLC32A1

Generalised epilepsy with febrile seizures plus, type 12

0.641

Developmental and epileptic encephalopathy 114

0.397

SCN4A

Congenital myopathy 22 A, classic

0.62

Paramyotonia congenita

0.376

EXT2

Exostoses, multiple, type II

0.633

Ovarian cancer

0.395

RECQL4

RAPADILINO syndrome

0.656

Ovarian cancer

0.422

POLR3B

Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism

0.607

Charcot-Marie-Tooth disease, demyelinating, type 1I

0.385

APOE

Lipoprotein glomerulopathy

0.539

Hyperlipoproteinemia, type III

0.316

NPR2

Acromesomelic dysplasia, Maroteaux type

0.616

Short stature with nonspecific skeletal abnormalities

0.395

PRNP

Gerstmann-Straussler disease

0.552

Creutzfeldt-Jakob disease

0.331

FLNA

Cardiac valvular dysplasia, X-linked

0.652

Otopalatodigital syndrome, type I

0.432

TTN

Cardiomyopathy, dilated, 1 G

0.584

Myopathy, myofibrillar, 9, with early respiratory failure

0.365

SDHD

Mitochondrial complex II deficiency, nuclear type 3

0.634

Pheochromocytoma

0.417

BEST1

Bestrophinopathy, autosomal recessive

0.598

Vitreoretinochoroidopathy

0.382

MECP2

Rett syndrome

0.615

Mental retardation, X-linked, syndromic 13

0.399

TSHR

Hypothyroidism, congenital, nongoitrous, 1

0.594

Ovarian cancer

0.379

TRPV4

Metatropic dysplasia

0.568

Hereditary motor and sensory neuropathy, type IIC

0.355

  1. Source data are provided as a Source Data file.